We’d like to introduce you to the newest member of our team, Dan Szot, who has joined us as VP Sales, Life Sciences and Healthcare. Dan brings more than 20 years of sales leadership and field operations experience to the Cambridge Semantics team, specializing in enterprise sales, research discovery and clinical applications. With his broad experience in all phases of the pharmaceutical business – from drug ideation to commercialization and product life-cycle management – Szot possesses a keen understanding of the value that cutting-edge data discovery and analytics can offer the industry.
Today marks the 100th day of the New Year, and we’d like to take a moment to reflect on a few of the more interesting developments we’ve seen thus far in the fast-moving big data analytics arena.
Last month, Cambridge Semantics held its inaugural Life Sciences Smart Data Discovery and Analytics Forum in Boston. At this forum, leaders in Life Sciences and Big Data met to discuss the application of smart data technology to research and development, clinical trial and healthcare data to gain more actionable insights and shorten the overall product lifecycle.
Data originates everywhere in the healthcare industry – in laboratories, within insurance agencies, in Electronic Medical Record (EMR) systems, etc. – and each of these sources represents a valuable set of information. Healthcare professionals need a comprehensive method that collects and transfers data across systems in a way that is reliable, secure and compliant. But because healthcare system formats are rarely ever the same, it becomes challenging to securely and efficiently share data between vast and diverse data and information sources.